Moderna (MRNA) PT Raised to $38 at BofA Securities
Tweet
Share
E-mailGet Alerts MRNA Hot Sheet
Price: $138.89 --0%
Rating Summary:
6 Buy, 22 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 8 | New: 13
Rating Summary:
6 Buy, 22 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 8 | New: 13
Join SI Premium – FREE
BofA Securities analyst Alec Stranahan raised the price target on Moderna (NASDAQ: MRNA) to $38.00 (from $34.00) while maintaining a Underperform rating.
You May Also Be Interested In
- Wolfe Research Upgrades Moderna (MRNA) to Peerperform
- Ventia Services Group Pty (VNT:AU) PT Raised to AUD6.33 at Canaccord
- Marvell (MRVL) PT Raised to $265 at Susquehanna
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
